BP Targets in CKD, Mortality, and SPRINT: What Have We Learned?
J Am Soc Nephrol
.
2017 Sep;28(9):2561-2563.
doi: 10.1681/ASN.2017060652.
Epub 2017 Jul 20.
Authors
Stephen C Textor
1
,
Gary L Schwartz
2
Affiliations
1
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota textor.stephen@mayo.edu.
2
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
PMID:
28729287
PMCID:
PMC5576952
DOI:
10.1681/ASN.2017060652
No abstract available
Keywords:
CKD; hypertension; mortality; targets.
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Antihypertensive Agents
Humans
Hypertension*
Renal Insufficiency, Chronic*
Substances
Antihypertensive Agents
Grants and funding
R01 DK100081/DK/NIDDK NIH HHS/United States
UL1 RR024150/RR/NCRR NIH HHS/United States